Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Dominating the Mastercard Endorsement Cycle: Six Fundamental Stages - 2An eye for an eye: People agree about the values of body parts across cultures and eras
- 3Putin critic gets six years in penal colony, vows hunger strike
- 4The Most Compelling Innovation Developments Somewhat recently
- 5China's Normal Ponders: A Visual Excursion
- Deadly heat worldwide prompts $300 million for climate health research at COP30
- The Way to Monetary Freedom: A Viable Aide
- Climate engineering would alter the oceans, reshaping marine life – our new study examines each method’s risks
- Would you ever turn to AI for companionship? 6% of Americans say they could — or already have.
- Vote In favor of Your Favored Menial helper Administration
- The Best 20 Photography Instagram Records to Follow
- A definitive Manual for Choosing Indoor Plants Ideal for Your Space
- Make your choice for the sweet that transports you to its nation of beginning!
- The Main 20 Gaming Control center Ever
